Costa Emanuel D, Priotti Josefina, Orlandi Silvina, Leonardi Darío, Lamas María C, Nunes Teresa G, Diogo Hermínio P, Salomon Claudio J, Ferreira M João
CQE, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisbon, Portugal.
IQUIR-CONICET, Suipacha 531, 2000 Rosario, Argentina; Área Técnica Farmacéutica, Facultad de Cs. Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, 2000 Rosario, Argentina.
Int J Pharm. 2016 Sep 25;511(2):983-93. doi: 10.1016/j.ijpharm.2016.08.009. Epub 2016 Aug 6.
The saturation solubility of PVP:PZQ physical mixtures (PMs) and solid dispersions (SDs) prepared from ethanol (E/E) or ethanol/water (E/W) by the solvent evaporation method at 1:1, 2:1 and 3:1 ratio (w/w) was determined. The presence of PVP improves the solubility of PZQ (0.31±0.01mg/mL). A maximum of 1.29±0.03mg/mL of PZQ in solution was achieved for the 3:1 SD (E/E). The amount of PZQ in solution depends on the amount of polymer and on the preparation method. Solid-state NMR (ssNMR) and DSC were used to understand this behavior. Results show that PMs are a mixture of crystalline PZQ with the polymer, while SDs show different degrees of drug amorphization depending on the solvent used. For E/W SDs, PZQ exists in amorphous and crystalline states, with no clear correlation between the amount of crystalline PZQ and the amount of PVP. For E/E SDs, formulations with a higher percentage of PZQ are amorphous with the components miscible in domains larger than 3nm ((1)H ssNMR relaxation measurements). Albeit its higher saturation solubility, the 3:1 E/E PVP:PZQ sample has a significant crystalline content, probably due to the water introduced by the polymer. High PVP content and small crystal size account for this result.
通过溶剂蒸发法,以1:1、2:1和3:1的比例(w/w),由乙醇(E/E)或乙醇/水(E/W)制备了聚乙烯吡咯烷酮(PVP)与吡喹酮(PZQ)的物理混合物(PMs)和固体分散体(SDs),并测定了它们的饱和溶解度。PVP的存在提高了PZQ的溶解度(0.31±0.01mg/mL)。对于3:1的SD(E/E),溶液中PZQ的最大含量达到了1.29±0.03mg/mL。溶液中PZQ的含量取决于聚合物的用量和制备方法。采用固体核磁共振(ssNMR)和差示扫描量热法(DSC)来理解这种行为。结果表明,PMs是结晶态PZQ与聚合物的混合物,而SDs根据所用溶剂的不同呈现出不同程度的药物非晶化。对于E/W SDs,PZQ以非晶态和结晶态存在,结晶态PZQ的量与PVP的量之间没有明显的相关性。对于E/E SDs,PZQ含量较高的制剂为非晶态,其组分在大于3nm的区域内互溶((1)H ssNMR弛豫测量)。尽管3:1的E/E PVP:PZQ样品具有较高的饱和溶解度,但仍有显著的结晶含量,这可能是由于聚合物引入了水。高PVP含量和小晶体尺寸导致了这一结果。